Clinical Trials List
2017-08-15 - 2023-11-30
Phase III
Terminated6
ICD-10L40.53
Psoriatic spondylitis
ICD-10L40
Psoriasis
-
Trial Applicant
AbbVie
-
Sponsor
-
Trial scale
Multi-Regional Multi-Center
-
Update
2026/04/01
Investigators and Locations
Co-Principal Investigator
- 張詩欣 風濕免疫科
- 洪偉哲 風濕免疫科
- Po-Yuan Wu Division of Dermatology
- Po-Hao Huang 風濕免疫科
The Actual Total Number of Participants Enrolled
0 Terminated
Co-Principal Investigator
- SONG-CHOU HSIEH Division of General Internal Medicine
The Actual Total Number of Participants Enrolled
0 Stop recruiting
Audit
None
Co-Principal Investigator
- Hsien-Tzung Liao Division of Rheumatology
- Wei-Sheng Chen Division of Rheumatology
- 劉德鈴 Division of Rheumatology
- Chang-Youh Tsai Division of Rheumatology
The Actual Total Number of Participants Enrolled
4 Stop recruiting
Audit
CRO
The Actual Total Number of Participants Enrolled
0 Stop recruiting
Co-Principal Investigator
Audit
None
Taiwan National PI
Co-Principal Investigator
- 陳彥輔 Division of Rheumatology
- Yu-Huei Huang Division of Dermatology
- Yao-Fan Fang Division of Rheumatology
- Shue-Fen Lo Division of Rheumatology
- TianMing Zhan Division of Rheumatology
- Ping-Han Tsai Division of Rheumatology
The Actual Total Number of Participants Enrolled
2 Stop recruiting
Audit
None
Co-Principal Investigator
- SONG-CHOU HSIEH Division of General Internal Medicine
The Actual Total Number of Participants Enrolled
0 Terminated
Condition/Disease
Objectives
Test Drug
Active Ingredient
Dosage Form
Dosage
Endpoints
Inclution Criteria
The Estimated Number of Participants
-
Taiwan
25 participants
-
Global
1640 participants
